Midwest Cancer Research Group

Skokie, Illinois 60625

0 studies enrolling now · 11 studies all time

What they study most

B-Cell Lymphoma, Breast Cancer, Colonic Neoplasms, Colorectal Neoplasms, Follicular Lymphoma, Marginal Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Non-Small-Cell Lung Cancer, Ovarian Cancer, Pleural Effusion, Malignant, Prostate Cancer

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality — Completed
• Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer — Completed
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes — Completed
• Non-small Cell Lung Cancer Registry — Completed
• ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere — Status unconfirmed
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome — Completed
• VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma — Completed